Publications by authors named "Tim Daynard"

Claim this Profile
Q
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model.
Jessica Kalra, Corinna Warburton, Karen Fang, Lincoln Edwards, Tim Daynard

Breast Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).
Lincoln A Edwards, Janet Woo, Lynsey A Huxham, Maite Verreault, Wieslawa H Dragowska, Tim Daynard

Mol Cancer Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Lincoln A Edwards, B Thiessen, Wieslawa H Dragowska, Tim Daynard, Marcel B Bally

Oncogene· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis